Zevra Therapeutics Inc. (NASDAQ: ZVRA)
$6.9900
+0.2100 ( +3.10% ) 743.4K
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Market Data
Open
$6.9900
Previous close
$6.7800
Volume
743.4K
Market cap
$357.59M
Day range
$6.6800 - $7.3140
52 week range
$3.8900 - $8.4399
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | May 13, 2024 |
10-q | Quarterly Reports | 78 | May 09, 2024 |
8-k | 8K-related | 16 | May 08, 2024 |
8-k | 8K-related | 14 | Apr 10, 2024 |
def | Proxies and info statements | 18 | Apr 03, 2024 |
10-k | Annual reports | 116 | Apr 01, 2024 |
8-k | 8K-related | 16 | Mar 28, 2024 |
8-k | 8K-related | 16 | Mar 27, 2024 |
8-k | 8K-related | 43 | Mar 05, 2024 |
8-k | 8K-related | 17 | Mar 04, 2024 |